Messaritakis, I.; Sfakianaki, M.; Vogiatzoglou, K.; Koulouridi, A.; Koutoulaki, C.; Mavroudis, D.; Tzardi, M.; Gouvas, N.; Tsiaoussis, J.; Souglakos, J.
Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients. J. Pers. Med. 2020, 10, 235.
https://doi.org/10.3390/jpm10040235
AMA Style
Messaritakis I, Sfakianaki M, Vogiatzoglou K, Koulouridi A, Koutoulaki C, Mavroudis D, Tzardi M, Gouvas N, Tsiaoussis J, Souglakos J.
Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients. Journal of Personalized Medicine. 2020; 10(4):235.
https://doi.org/10.3390/jpm10040235
Chicago/Turabian Style
Messaritakis, Ippokratis, Maria Sfakianaki, Konstantinos Vogiatzoglou, Asimina Koulouridi, Chara Koutoulaki, Dimitrios Mavroudis, Maria Tzardi, Nikolaos Gouvas, John Tsiaoussis, and John Souglakos.
2020. "Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients" Journal of Personalized Medicine 10, no. 4: 235.
https://doi.org/10.3390/jpm10040235
APA Style
Messaritakis, I., Sfakianaki, M., Vogiatzoglou, K., Koulouridi, A., Koutoulaki, C., Mavroudis, D., Tzardi, M., Gouvas, N., Tsiaoussis, J., & Souglakos, J.
(2020). Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients. Journal of Personalized Medicine, 10(4), 235.
https://doi.org/10.3390/jpm10040235
